stroke

For November 2017, we have selected: Mittal S, Bjørnevik K, Im DS, et al. ß2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease. Science 2017;140:2295-2305. Disturbed proteostasis of α-synuclein is now thought to play a critical role in the pathogenesis of Parkinson’s disease (PD). Physiological functions of this protein include synaptic transport as well as involvement in the metabolism of membrane phospholipids, and in the differentiation and survival of dopaminergic neurons.

Report from Dr Meri Grigoryan, from Yerevan, Armenia visiting the Department of Neurology, Universitatsklinikum Heidelberg, Germany under the supervision of prof. Peter Ringleb

The new CME article October 2017: “European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology” is online now! Please log-in and browse to the LEARN section on the… Continue Reading

A new guideline on cerebral venous thrombosis (CVT) diagnosis and treatment issued by the European Stroke Organization (ESO) and endorsed by the European Academy of Neurology (EAN) was recently published in ESO (long version) and EAN (abbreviated version) official journals [1, 2].

It is a pleasure to share with the European neurological community the outcome of the first teaching course for rare neurological diseases. The course took place in Cluj-Napoca, Romania, from 7th to 9th September 2017.

Please find below articles from Belgian authors and co-authors that were published in the European Journal of Neurology

For October 2017, we have selected: Andersen G, Hedermann G, Witting N, Duno M, Andersen H, Vissing J. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study. Brain 2017;140:2295-2305. Patients with myotonia congenita and paramyotonia congenita can be disabled by the myotonic phenomenon in the activities of daily living, with a huge impact on their quality of life.

With great gratitude and pleasure I report back about the RTC which took place in Odessa 27-29 April 2017. First of all, I would like to thanks the European Academy of Neurology, Head office Julia Mayer, Eveline Sipido, the EAN… Continue Reading

or August 2017, we have selected: The Writing Group on behalf of the Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 2017;16:505-512. There is evidence that oxidative stress induced by free radicals is a key factor of progression in amyotrophic lateral sclerosis (ALS).

The 18th course of the Spring School attracted attention of 187 colleagues from 36 countries. Due to the capacity reasons we were forced to refuse one third of the applicants. Traditionally the highest interest was from Russia – 29, Uzbekistan - 21 and Romania - 19. As usually we had again delegates from mediterranian Africa. this year, we had 90 female participants and 31 male participants.

Please find below articles from Serbian authors and co-authors that were published in the European Journal of Neurology.

Chairpersons:
Bernard Uitdehaag, Guenther Deuschl, Paul Boon
during the Highlight session the most prominent topics of the congress were given special recognition: Stroke
Veerle De Herdt, , Belgium Multiple Sclerosis
Rogier Q. Hintzen, Rotterdam, The Netherlands Degenerative disorders including dementia… Continue Reading

ESO/EAN symposium 7: uncommon cerebrovascular diseases Chairpersons:
Stefan Engelter, Basel, Switzerland
C.J.M. (Karin) Klijn, AMERSFOORT, The Netherlands Reversible cerebral vasoconstriction syndrome: how to recognise it?
Anne Ducros, Montpellier, France Cervical artery dissection: where are we now?
Stefan Engelter, Basel, Switzerland… Continue Reading

The third congress of the EAN will take place in Amsterdam from June 24-27. This is of course well known and already in the agenda of many European neurologists! What makes this EAN congress extra special, besides the exciting program… Continue Reading